The federal government is appointing members to an implementation advisory group to support the launch of its national strategy for drugs for rare diseases. The members from Canada’s private payer community include: Stephen Frank, president and chief executive officer of the Canadian Life and Health Insurance Association; Joanne Jung, Canadian pharmacy and clinical practice leader at […]